On forums, they are often presented as complementary, but how many peer-reviewed studies actually validate this combination
At the molecular level, BPC-157 activates VEGFR2 signaling to drive new vessel formation at wound sites, mobilizes FAK-paxillin complexes that govern cell adhesion and directional migration, and upregulates growth hormone receptor expression in fibroblasts dramatically amplifying the healing cascade
For example, in studies, BPC-157 has shown promise in healing tendon-to-bone injuries much quicker than traditional treatments
Results can vary, and NAD+ injection is usually one component of a broader wellness or treatment plan
Neither peptide is FDA-approved for human therapeutic use
Tirzepatide best result: 22.5% body weight loss over 72 weeks on the 15mg dose, versus 2.4% for placebo